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Objective: Dietary carbohydrate/fat ratio may affect phosphorus metabolism because both 29 
calcium and phosphorus are regulated by similar metabolic mechanisms, and a high-fat 30 
diet (HF) induces deleterious effects on the absorption of dietary calcium. We hypothesized 31 
that the HF induces an increase in phosphorus absorption; therefore, this study aimed to 32 
evaluate the effects of differences in the quantity and quality of dietary fat on phosphorus 33 
metabolism over the short and long term. 34 
Research Methods & Procedures: Eighteen 8-week-old Sprague–Dawley male rats were 35 
fed an isocaloric diet containing varied carbohydrate/fat energy ratio and sources of fat 36 
(control diet [Control], HF, and high saturated-fat diet [HF-SFA]). At 3 days and 7 weeks 37 
after the allocation and initiation of the test diets, feces and urine were collected and used 38 
for phosphorus and calcium measurement. 39 
Results: The fecal phosphorous concentration (F-Pi) was lower in the HF-SFA group than 40 
in the other two groups; however, the urine phosphorus concentration (U-Pi) was 41 
significantly higher in the HF-SFA group than the other two groups when the rats were fed 42 
over the short (p<0.01) and long term (p<0.01 vs Control group, p<0.05 vs HF group). 43 
There were no significant differences in type-IIa sodium-phosphate cotransporter 44 
(NaPi-2a) and type-IIc sodium-phosphate cotransporter (NaPi-2c) mRNA expression, 45 





sodium-phosphate cotransporter (NaPi-2b) and type-III sodium-phosphate cotransporter 47 
(Pit-1) mRNA in the duodenum was higher in the HF and HF-SFA groups than in the 48 
Control group (p<0.05), although there were no significant differences in these in the 49 
jejunum. 50 
Conclusions: Our results indicate that HF, particularly HF-SFA, increases intestinal 51 
phosphate absorption compared with Control. 52 
 53 






Hyperphosphatemia leads to vascular smooth-muscle calcification, endothelial 56 
dysfunction [1, 2], and an increased risk of cardiovascular events and death in patients 57 
undergoing dialysis and those with chronic kidney disease (CKD) [3-6]. In addition, 58 
previous studies [7-9] have reported that in individuals with normal renal function, the risk 59 
of cardiovascular diseases (CVDs) and mortality increases with increasing serum 60 
phosphorus levels; thus, it suggests that the control of serum phosphorus levels is 61 
important in patients with impaired renal function and individuals with normal renal 62 
function. 63 
Phosphorus homeostasis is primarily regulated by its absorption in the small 64 
intestine and by renal reabsorption and excretion. Excessive phosphorus intake stimulates 65 
the parathyroid glands to secrete parathyroid hormone (PTH) and bones to secrete 66 
fibroblast growth factor 23 (FGF23) [10-12]. PTH promotes urinary phosphorus excretion 67 
by decreasing the expression of the type-IIa and IIc sodium-phosphate cotransporters 68 
(NaPi-2a, NaPi-2c) in the renal proximal tubule [13]. FGF23 reduces serum phosphate 69 
levels by decreasing the expression of NaPi-2a and NaPi-2c in the renal proximal tubule 70 
and inhibiting vitamin D activation by impairing the production of 1α-hydroxylase and 71 
elevating the production of 24-hydroxylase [14-19]. This results in inhibitory effects on 72 





The Western-type diet, which is rich in animal products, such as meat and dairy, has 74 
become more globally widespread. Moreover, together with highly developed 75 
food-preparation techniques and food convenience, the use of processed food has also 76 
become more widespread. Processed food uses many food additives, including phosphorus, 77 
which is grouped into organic and inorganic. Organic phosphorus is divided into plant and 78 
animal phosphorus. Animal phosphorus is more highly absorbed than plant phosphorus 79 
[20], and inorganic phosphorus is more highly absorbed than organic phosphorus [21, 22]; 80 
therefore, increasing the intake of animal products and processed foods will cause 81 
excessive consumption of well-absorbed phosphorus. In addition, the Western-type diet is 82 
rich in fats, especially saturated fat. It has been reported in epidemiological studies [23, 24] 83 
that a high-fat diet (HF) is associated with osteoporosis. Another study on animals [25] has 84 
demonstrated that HF results in deleterious effects on the absorption of dietary calcium; 85 
therefore, the dietary carbohydrate-to-fat ratio might affect phosphorus metabolism 86 
because calcium and phosphorus are regulated by similar metabolic mechanism. However, 87 
there are few reports on this and the detailed mechanisms are unclear. 88 
Thus, the purpose of this study was to evaluate the effects of the differences in the 89 
quantity and quality of dietary fat on phosphorus metabolism over periods of short- and 90 






MATERIALS AND METHODS 93 
Animals 94 
Eighteen male Sprague–Dawley rats 8 weeks old (Japan SLC Inc, Shizuoka, Japan) were 95 
housed in individual cages and maintained on a 12-h artificial light/ dark cycle throughout 96 
the study. Before the study, the rats were initially fed standard powder diets (MF, Oriental 97 
Yeast Co., Ltd., Tokyo, Japan) for 10 d to adapt to their surroundings and conditions. The 98 
rats were allowed free access to water. 99 
Diets 100 
The compositions of the test diets are shown in Table 1. Three types diets were prepared 101 
depending on the carbohydrate/fat energy ratio and source of fat as follows: control diet 102 
(Control): 75/10, soy bean oil; HF: 45/40, soy bean oil; high saturated-fat diet (HF-SFA): 103 
45/40, soy bean oil + lard. The protein energy ratios of the diets were kept constant for all 104 
groups (14.9%). The phosphorus, calcium, and vitamin D/energy ratios were matched in all 105 
diets. The Control was based on the nutrient composition of AIN-93M, which is the 106 
standard diet for rat and mice. The HF and HF-SFA were defined as a diet with a higher fat 107 
energy ratio than the Control diet. 108 
Experimental design 109 
The rats were weighed and assigned to one of the three dietary groups— Control, HF, or 110 





feeding and water ad libitum for 8 weeks. Food intakes were weighed daily and body 112 
weights were measured weekly during the experimental period. 113 
The rats were allocated and fed one of the three diets for 3 d after being placed in a 114 
cage based on diet type and the feces and urine were collected to measure the short-term 115 
in/out balance. After 7 weeks, the feces and urine were collected in a similar manner to 116 
measure the long-term in/out balance. The collected feces and urine samples were used to 117 
measure the fecal/urine phosphorus and calcium, respectively. 118 
At the end of the long-term period (after 8 weeks), all rats were fasted for 12 h and 119 
then dissected. Under pentobarbital sodium anesthesia, 4 mL of blood samples were taken 120 
from the jugular vein. The rats were sacrificed and kidney and gut mucosa samples were 121 
harvested. Blood samples were centrifuged at 12000 rpm and 4ºC for 5 min. The obtained 122 
serum samples were dispensed into storage containers and stored at −80ºC until analysis of 123 
serum phosphorus levels (S-Pi), serum calcium levels (S-Ca), serum intact PTH levels 124 
(S-PTH), serum 1,25-dihydroxyvitamin D levels (S-1,25(OH)2D), and serum intact FGF23 125 
levels (S-iFGF23). This study was approved by the University of Shizuoka (Shizuoka, 126 
Japan) Animal Care and Use Committee and developed according to the institution’s 127 
guidelines for the care and use of laboratory animals. 128 





Feces were dried at 110ºC for 12 h and micropulverized. The samples were then ashed at 130 
250ºC for 3 h, at 350ºC for 3 h, and at 550ºC for 24 h. The samples were then dissolved in 131 
25 mL 1% hydrochloric acid (HCl). F-Pi was measured using the vanadomolybdate 132 
method and F-Ca was measured using the calcium–cresol complexone method. The rates 133 
of excretion to food intake in the feces are given as percentages. 134 
 135 
Urine and blood data 136 
Urine phosphorus concentration (U-Pi) and S-Pi were measured using the Phospha C-Test 137 
Wako (Wako Pure Chemical Industries, Ltd., Osaka, Japan). Urine calcium concentration 138 
(U-Ca) and S-Ca were measured using the Calcium E-Test Wako (Wako). S-PTH was 139 
measured using the enzyme-linked immunosorbent assay (ELISA) kit (Quidel, San 140 
Clemente, CA, USA). S-1,25(OH)2D was measured using the radioimmune assay (RIA) 141 
method (FUJIREBIO Inc., Tokyo, Japan). S-iFGF23 was measured using the ELISA 142 
method (KAINOS Laboratories, Inc., Tokyo, Japan). The rate of excretion to food intake in 143 
the urine is shown in percentages. 144 
 145 
RNA extraction and cDNA synthesis 146 
Total RNA was extracted using TRIzol reagent according to the manufacturer’s 147 





Real Time; TaKaRa Bio Inc., Shiga, Japan), and RNase Free dH2O (TaKaRa) were reacted 149 
in a 20 μL, and cDNA was synthesized. 150 
Real-time quantitative reverse transcription polymerase chain reaction 151 
The expression of each gene was determined using real-time quantitative reverse 152 
transcription polymerase chain reaction (qRT-PCR) with the Thermal Cycler Dice Real 153 
Time System (TaKaRa); the relative fold change in gene expression indicated the ratio 154 
from the Control group. One microliter of synthesized cDNA was used as a template and 155 
subjected to an amplification reaction using specific primers for each gene (Table 2); it was 156 
confirmed using the analysis of the melting curve that a single PCR product was obtained. 157 
The specificity of the amplified products was further confirmed using electrophoresis with 158 
3% ethidium bromide gel, and the expression level of each gene was corrected by 18S 159 
ribosomal RNA. 160 
Statistical analyses 161 
The data are shown as the mean ± SE. After confirming the normality of each group, 162 
comparisons across groups were conducted by one-way analysis of variance for a normal 163 
distribution and by the Kruskal–Wallis test for an abnormal distribution. The Tukey’s 164 
multiple comparison test was subsequently conducted, and a p value < 0.05 was regarded 165 
as statistically significant. All statistical analyses were performed using the SPSS ver. 22 166 






Food consumption and body weight 169 
There were no significant differences in food consumption in each group during the study 170 
period. Initial body weight in Control, HF and HF-SFA group was 307.4 ± 2.8, 307.5 ± 2.8 171 
and 307.3 ± 2.4 g, respectively. At the end of the study, the body weight in each group was 172 
as follows: Control group, 422.3 ± 5.9 g; HF group, 445.7 ± 6.3 g; and HF-SFA group, 173 
433.8 ± 4.6 g. There were no significant differences in initial body weight among the 174 
groups. At the end of the study, the body weight of the those in the HF group was 175 
significantly higher than that of those in the Control group (p < 0.05). 176 
Short-term phosphorus and calcium balance 177 
After 3 d, F-Pi was low in the HF-SFA group compared with that in the HF group (p = 178 
0.057). U-Pi was significantly higher in the HF-SFA group than in the other two groups (p 179 
< 0.01). F-Ca in the HF-SFA group was significantly higher than that in the Control group 180 
(p < 0.05) and tended to be higher than that in the HF group (p = 0.091). U-Ca was 181 
significantly lower in the HF and HF-SFA groups than in the Control group (p < 0.05) (Fig. 182 
1). 183 
Long-term phosphorus and calcium balance 184 
After 7 weeks, the rate of excretion to food intake in the feces and urine is presented as 185 





group (p < 0.05). U-Pi in the HF-SFA group was significantly higher than that in the other 187 
two groups (p < 0.01 vs Control group, p < 0.05 vs HF group). There were no significant 188 
differences in F-Ca among the groups. U-Ca in the HF and HF-SFA groups was 189 
significantly lower than that in the Control group (p < 0.01 vs HF group, p < 0.05 vs 190 
HF-SFA group) (Fig. 2). 191 
Biochemical examination of blood 192 
The serum parameters are provided in Fig. 3. There were no significant differences in S-Pi 193 
among the groups. S-Ca in the HF and HF-SFA groups were significantly lower than that 194 
in the Control group (p < 0.05). There were no significant differences in S-1,25(OH)2D and 195 
S-PTH among the groups, but S-1,25(OH)2D and S-PTH had a tendency be high in the 196 
high-fat groups, especially in the HF-SFA group, than in the Control group. S-iFGF23 in 197 
the HF and HF-SFA groups was significantly higher than that in the Control group (p < 198 
0.05). 199 
Gene expression involved in phosphorus transport in the kidney and intestine 200 
There were no significant differences in mRNA expression levels of NaPi-2a and NaPi-2c 201 
among the groups (data not shown). 202 
The expression of phosphorus transport-related genes NaPi-2b and Pit-1 in the 203 
duodenum and jejunum are shown in Fig. 4. Duodenal NaPi-2b mRNA expression in the 204 





be lower than that in the HF-SFA group. The expression level of Pit-1 mRNA in the 206 
duodenum of the HF and HF-SFA groups was significantly higher than that in the Control 207 
group (p < 0.05). On the other hand, there were no significant differences among the 208 
groups in NaPi-2b and Pit-1 mRNA expression in the jejunum. There were no significant 209 
differences in mRNA expression levels of intestinal alkaline phosphatase (IAP) among the 210 






Elevated serum phosphorus levels are known to promote vascular calcification, arterial 213 
sclerosis, and cardiovascular diseases [1, 2]. These evidences were observed not only in 214 
patients with CKD [3-6] but also in individuals with normal renal function [7-9]. Therefore, 215 
it is recommended that serum phosphorus levels should be maintained within the 216 
appropriate range. Moreover, regulation of serum phosphorus may be affected by the 217 
dietary fat. The aim of this study was to examine the effects of the quantity and quality of 218 
different dietary fats on phosphate metabolism. F-Pi was lower in the HF-SFA group than 219 
in the other two groups; however, U-Pi was significantly higher in the HF-SFA group than 220 
in the other two groups (Figs. 1, 2). Phosphorus homeostasis is regulated by its absorption 221 
in the small intestine, by migration between blood and tissues, and by renal reabsorption 222 
(excretion in the urine). Feces contain phosphorus that has not been absorbed in the 223 
intestine and that is secreted into the digestive juice. In the urine, the amount of 224 
phosphorus excreted is equivalent to the apparent absorption [26]. An increase in U-Pi has 225 
been reported to reflect an increase in intestinal phosphate absorption [27, 28]; therefore, 226 
increase in the apparent phosphate absorption was observed in groups fed a HF, 227 
particularly the HF-SFA group. Some other factors might be involved in these results. 228 
First, it is presumed that fat inhibits calcium absorption. It was suggested that the HF 229 





soap—water-insoluble calcium salts of fatty acids [29]. Furthermore, Xiao et al. [25] have 231 
indicated that calcium absorption is significantly reduced and calcium transport-related 232 
gene expression is downregulated in mice fed HF. In this study, a significantly reduction in 233 
U-Ca in two HF groups was observed. Urine calcium excretion is almost equivalent 234 
amount of apparent calcium absorption [30]. In our study, it is suggested the following; 235 
there was no significant difference in fecal calcium excretion rate, but amount of calcium 236 
absorption in HF and HF-SFA groups were less than that of Control group, resulting in low 237 
S-Ca in HF and HF-SFA group. Calcium absorption is an important determinant for 238 
phosphorus absorption because calcium and phosphorus form calcium phosphate and 239 
insoluble calcium–phosphorous complexes, and are then excreted into the feces [31]. Our 240 
data in which HF increased phosphorus absorption might be explained by the following 241 
mechanism: formation of calcium soaps from fatty acids and calcium reduced the amount 242 
of phosphorus that binds to calcium; therefore, absorption of free phosphorus could then be 243 
easily increased. A previous study [32] has shown that rats fed a low-carbohydrate diet/HF 244 
show increases in the apparent rate of phosphate absorption, which is in agreement with 245 
the results of our study. In addition, differences in the digestibility of fatty acids might be 246 
involved. The digestibility of saturated fatty acids is relatively lower than that of other fatty 247 
acids [33-35]. It was suggested that the HF-SFA group, which consumed lard as a major 248 





in the intestine compared with those in the HF group, which consumed soy bean oil as a 250 
major source of fat. 251 
 The next possible factor for these results is the enhancement of intestinal 252 
permeability. Intestinal phosphate transport could be classified into either transcellular or 253 
paracellular [36, 37]. A tight junction is a major determinant in intestinal permeability [38]. 254 
Suzuki et al. [39] have reported that HF increases intestinal permeability by suppressing 255 
the expression of tight junction proteins in non-obese rats. HF elevates blood tumor 256 
necrosis factor-α (TNF-α) and monocyte chemoattractant protein-1 (MCP-1) [40], and 257 
induces the dysfunction of the intestinal epithelial barrier in the synergy between 258 
interferon-γ (IFN-γ) and TNF-α [41]. Moreover, a previous mice study [42] has reported 259 
that HFs (soybean oil, lard, or a combination of these) increase total bile acid (BA) and 260 
total secondary BA concentrations in the cecum compared with those in the control diet. 261 
Most BAs appear to have the ability to induce intestinal hyperpermeability [39, 43-46]; 262 
therefore, increased sodium-independent transport resulting from increased intestinal 263 
permeability that is accompanied by the enhancement of inflammatory responses and bile 264 
secretion might be involved, in part, in the increase in intestinal phosphate absorption in 265 
the HF groups. 266 
 To investigate, in particular, the mechanism by which intestinal phosphate 267 





gene expression in the kidney and intestine at the end of the study. There were no 269 
significant differences in NaPi-2a and NaPi-2c mRNA expressions, which are renal 270 
phosphate transport-related genes; however, NaPi-2b and Pit-1 mRNA expressions in the 271 
duodenum were higher in the HF and HF-SFA groups than in the Control group, although 272 
there were no significant differences in the expression levels in the jejunum (Figs. 4A–D). 273 
The factor that increases duodenal NaPi-2b and Pit-1 mRNA expression in the HF groups 274 
appears to change with S-1,25(OH)2D and S-iPTH. A previous mouse study [25] has 275 
demonstrated that a HF decreases apparent calcium absorption and serum calcium levels 276 
and elevates serum 1,25(OH)2D and iPTH levels. Our study has observed the same 277 
tendency. 1,25(OH)2D administration has also been reported to upregulate intestinal 278 
NaPi-2b expression and increase phosphate absorption [47, 48]. In addition, Brown et al. 279 
[49] have shown that orally administrating vitamin D analog to mice every 2 d for 8 d 280 
upregulates NaPi-2b expression in the duodenum and jejunum and increases intestinal 281 
phosphate absorption. It is believed from the present study that long-term consumption of 282 
HF elevates S-1,25(OH)2D and S-iPTH from impaired calcium absorption, and, as a result, 283 
upregulates duodenal NaPi-2b expression and intestinal phosphate absorption. Moreover, 284 
NaPi-2b transport activity increases in basicity because the NaPi-2b substrate is a divalent 285 
phosphoric acid (HPO4
2-
) rather than a monovalent phosphoric acid (H2PO4
−
) [50-52]. The 286 





deoxycholate solution, one of the secondary BAs, was reported to significantly increase the 288 
pH of the mucosal surface [53]. In addition, increasing amino acids, fatty acids, and BAs in 289 
the lumen after meals promotes bicarbonate secretion in the duodenum [54]; therefore, it is 290 
possible that intestinal NaPi-2b is activated through the increased pH of the intestinal 291 
lumina resulting from BA and bicarbonate secretion after ingesting HF. 292 
 S-iFGF23 in the HF and HF-SFA groups was significantly higher than that in the 293 
Control group; however, there were no significant differences in S-Pi among the groups, in 294 
this study. FGF23 is one of the hormones that maintain the homeostasis of serum 295 
phosphorus levels. Excessive phosphorus intake stimulates secretion of FGF23 [10-12], 296 
and reduces serum phosphate levels by decreasing phosphorus absorption in the small 297 
intestine and reabsorption in the kidney [14-19]. HF and HF-SFA groups had higher 298 
intestinal phosphorus absorption than Control group, moreover, FGF23 secretion increased. 299 
As a result, it is suggested that there was no difference in S-Pi among the groups. Although 300 
S-iFGF23 in the HF and HF-SFA groups was significantly higher than that in the Control 301 
group, the expression of phosphorus transport-related genes in the duodenum was 302 
significantly higher in the HF and HF-SFA group than that in the Control group. This 303 
warrants the need for further studies. It has been reported that chronic hyper S-iFGF23 304 
induced FGF23 resistance [55], which might be involved. 305 





(Figs. 4E, F). IAP plays an important role in intestinal phosphorus absorption by 307 
hydrolyzing phosphate esters into inorganic phosphorus and alcohol. Long-chain and 308 
medium-chain triglycerides increase IAP expression and/or activity [56-59]. Moreover, 309 
1,25(OH)2D has been reported to increase IAP activity and expression in the experiments 310 
using Caco-2 cells [60]; therefore, IAP activity in the HF-SFA group might be increased 311 
over that in the other groups, even if IAP expression were similar among the groups. 312 
 313 
Conclusion 314 
Our results indicate that HF, especially a HF-SFA, increases intestinal phosphate 315 
absorption over that with a Control. This phenomenon was considered to be related to 316 
increases in free phosphorus and decreases in calcium absorption (Figure 5); this may 317 
trigger increase in the serum phosphorus levels. It was suggested that not only the 318 
phosphorus intake but also the carbohydrate/fat ratio and the quality of the dietary fat are 319 
important for the control of serum phosphorus levels and helpful in preventing the onset of 320 
cardiovascular events. 321 
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Table 1. Composition of experimental diets
Group Control HF HF-SFA
Protein (% of Energy) 14.9 14.9 14.9
　   Milk casein (g) 14.2 17.1 17.1
　   L-Cystein (g) 0.18 0.18 0.18
Fat (% of Energy) 10 40 40
 　  Soybean oil (g) 4.26 20.60 4.26
  　 Lard (g) 0 0 16.34
Carbohydrate (% of Energy) 75.1 45.1 45.1
　   Corn Starch (g) 45.4262 30.4213 30.4213
  　 α-Corn Starch (g) 15.1 10 10
 　  Sucrose (g) 10 10 10
Fiber (cellulose) (g) 5 5 5
Mineral mixture (g) 2.765679 2.765679 2.765679
Vitamin mixture (g) 0.025875 0.025875 0.025875
KH2PO4 (g) 1.0073 1.3945 1.3945
CaCO3 (g) 0.0757 0.348 0.348
Choline bitartrate (g) 0.25 0.25 0.25
Tert-butylhydroquinone (g) 0.0008 0.0008 0.0008
Total (g) 100 100 100
Energy: 80kcal (g/day) 20.79 17.25 17.25
P (mg/80kcal) 110.32 110.32 110.32
Ca (mg/80kcal) 110.32 110.33 110.33
Vitamin mixture (g/80kcal) 2.0789 2.0789 2.0789






Table 2. Primer used for real-time quantitative RT-PCR
















NaPi-2a: the type IIa sodium-phosphate cotransporter, NaPi-2c:
the type IIc sodium-phosphate cotransporter, NaPi-2b: the type
IIb sodium-phosphate cotransporter, Pit-1: the type III sodium-
phosphate cotransporter 1, IAP: intestinal alkaline phosphatase.
F: forward, R: reverse
